Biolife Solutions (BLFS) Shares Outstanding (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Shares Outstanding data on file, last reported at $48.8 million in Q1 2026.

• Quarterly Shares Outstanding rose 2.69% year-over-year to $48.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.8 million (up 2.69% YoY) and the FY2025 annual result came in at $48.2 million, up 2.75% from the prior year.
• Shares Outstanding grew to $48.8 million in Q1 2026 per BLFS's latest filing, from $48.2 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $48.8 million in Q1 2026 and bottomed at $42.3 million in Q1 2022.
• The 5-year median for Shares Outstanding is $45.7 million (2024), against an average of $45.4 million.
• The widest annual swing landed in 2022, when Shares Outstanding increased 25.86%; it then gained 2.27% in 2023.
• Tracing BLFS's Shares Outstanding over 5 years: stood at $42.8 million in 2022, then climbed by 5.45% to $45.2 million in 2023, then rose by 3.85% to $46.9 million in 2024, then advanced by 2.75% to $48.2 million in 2025, then gained by 1.3% to $48.8 million in 2026.
• Per Business Quant, the three latest BLFS Shares Outstanding figures stand at $48.8 million (Q1 2026), $48.2 million (Q4 2025), and $48.0 million (Q3 2025).

Peer Comparison